A Study of REC-4881 in Participants With Cancers Which Have an AXIN1 or APC Mutation

Stopped Study was terminated due to sponsor decision. This decision was not related to safety concerns.

Conditions

• AXIN1 Gene Mutation
• APC Gene Mutation
• Solid Tumor

Interventions

• DRUG: REC-4881

Sponsor

Recursion Pharmaceuticals Inc.